MAPT and Alzheimer disease: Regarding O-GlcNAcylation, Liu et al. revealed that downregulation of tau O-GlcNAcylation leads to abnormal hyperphosphorylation of tau and neurofibrillary degeneration in AD (Liu et al. 2004, 2009).